Psychoneuroendocrinology
Volume 31, Issue 6 , Pages 761-768 , July 2006

Melatonin levels in drug-free patients with major depression from the southern hemisphere

  • Livia A. Carvalho

      Affiliations

    • Department of Physiology, Institute of Biosciences, Universidade de São Paulo, Rua do Matão, travessa 14 sala 323, CEP 05508-900 São Paulo, SP, Brazil
    • Corresponding Author InformationCorresponding author. Address: Division of Psychological Medicine, Section of Clinical Neuropharmacology, Stress, Psychiatry and Immunology Laboratory (SPI-Lab), King's College London, PO51, Institute of Psychiatry, 1 Windsor Walk, Room 103, London SE5 8AF, UK. Tel.: +44 20 7848 0352; fax: +44 20 7848 0051.
    • ,
  • Clarice Gorenstein

      Affiliations

    • Laboratory of Medical Investigation-23, Psychopharmacology, Department of Pharmacology, Institute of Biomedical Sciences, Institute of Psychiatry, Universidade de São Paulo, HC-FMUSP, Rua Dr Ovídio Pires de Campos, 785, Térreo, CEP 05403-010 São Paulo, SP, Brazil
    • ,
  • Ricardo A. Moreno

      Affiliations

    • GRUDA—Grupo de Estudos de Doenças Afetivas, Institute of Psychiatry, HC-FMUSP, Dr Ovídio Pires de Campos, 225, Prédio da Administração, Andar M, sala 03, CEP 05403-010 São Paulo, SP, Brazil
    • ,
  • Regina P. Markus

      Affiliations

    • Department of Physiology, Institute of Biosciences, Universidade de São Paulo, Rua do Matão, travessa 14 sala 323, CEP 05508-900 São Paulo, SP, Brazil

Received 12 August 2005 ,Revised 28 February 2006 ,Accepted 28 February 2006.

References 

  1. American Psychiatry Association. Diagnostic and statistical of mental disorders diagnostic and statistical of mental disorders. Washington, DC: APA Press, Inc.; 1994;
  2. Arendt J, Wirz-Justice A, Bradtke J. Annual rhythm of serum melatonin in man. Neurosci. Lett. 1977;7:327–330
  3. Beck-Friis J, Kjellman BF, Aperia B, Unden F, von Rosen D, Ljunggren JG, et al. Serum melatonin in relation to clinical variables in patients with major depressive disorder and a hypothesis of a low melatonin syndrome. Acta Psychiatr. Scand. 1985;71:319–330
  4. Brown R, Kocsis JH, Caroff S, Amsterdam J, Winokur A, Stokes PE, et al. Differences in nocturnal melatonin secretion between melancholic depressed patients and control subjects. Am. J. Psychiatry. 1985;142:811–816
  5. Claustrat B, Chazot G, Brun J, Jordan D, Sassolas G. A chronobiological study of melatonin and cortisol secretion in depressed subjects: plasma melatonin, a biochemical marker in major depression. Biol. Psychiatry. 1984;19:1215–1228
  6. Cook MR, Graham C, Kavet R, Stevens RG, Davis S, Kheifets L. Morning urinary assessment of nocturnal melatonin secretion in older women. J. Pineal Res. 2000;28:41–47
  7. Copinschi G, Van Onderbergen A, L'Hermite-Baleriaux M, Szyper M, Caufriez A, Bosson D, et al. Effects of the short-acting benzodiazepine triazolam, taken at bedtime, on circadian and sleep-related hormonal profiles in normal men. Sleep. 1990;13:232–244
  8. Crasson M, Kjiri S, Colin A, Kjiri K, L'Hermite-Baleriaux M, Ansseau M, et al. Serum melatonin and urinary 6-sulfatoxymelatonin in major depression. Psychoneuroendocrinology. 2004;29:1–12
  9. Demisch L. Clinical pharmacology of melatonin regulation. In:  Yu H-SRRJ editors. Melatonin, Biosynthesis, Physiological Effects and Clinical Applications. Boca Raton, FL: CRC Press; 1993;p. 513–540
  10. First MB, Spitzer RL, Gibbon M, Williams JB. Structured clinical interview for DSM-IV axis I disorders—patient edition, version 2.0 (SCID-I/P). Biometrics Research Department; 1995;
  11. Gibbons RD, Davis JM, Hedeker DR. A comment on the selection of ‘healthy controls’ for psychiatric experiments. Arch. Gen. Psychiatry. 1990;47:785–786
  12. Gorenstein C, Lotufo-Neto F, Melo M, Lauriano V, Guerra DA, Gentil V. Untreated psychopathology of candidates to normal volunteers. J. Clin. Psychopharmacol. 1997;17:238–239
  13. Gorenstein C, Gentil V, Melo M, Lotufo-Neto F, Lauriano V. Mood improvement in ‘normal’ volunteers. J. Psychopharmacol. 1998;12:246–251
  14. Graham C, Cook MR, Kavet R, Sastre A, Smith DK. Prediction of nocturnal plasma melatonin from morning urinary measures. J. Pineal Res. 1998;24:230–238
  15. Griefahn B, Brode P, Blaszkewicz M, Remer T. Melatonin production during childhood and adolescence: a longitudinal study on the excretion of urinary 6-hydroxymelatonin sulfate. J. Pineal Res. 2003;34:26–31
  16. Guy M. Clinical global impressions. ECDEU Assessment Manual for Psychopharmacology Revised-DHEW. Washington, DC: Government Printing Office; 1976;(Publication number ADM 76-338)
  17. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry. 1960;23:56–62
  18. Harding TW, de Arango MV, Baltazar J, Climent CE, Ibrahim HH, Ladrido-Ignacio L, et al. Mental disorders in primary health care: a study of their frequency and diagnosis in four developing countries. Psychol. Med. 1980;10:231–241
  19. Hartter S, Wang X, Weigmann H, Friedberg T, Arand M, Oesch F, et al. Differential effects of fluvoxamine and other antidepressants on the biotransformation of melatonin. J. Clin. Psychopharmacol. 2001;21:167–174
  20. Klante G, Brinschwitz T, Secci K, Wollnik F, Steinlechner S. Creatinine is an appropriate reference for urinary sulphatoxymelatonin of laboratory animals and humans. J. Pineal Res. 1997;23:191–197
  21. Kripke DF, Youngstedt SD, Rex KM, Klauber MR, Elliott JA. Melatonin excretion with affect disorders over age 60. Psychiatry Res. 2003;118:47–54
  22. Kripke DF, Jean-Louis G, Elliott JA, Klauber MR, Rex KM, Tuunainen A, et al. Ethnicity, sleep, mood, and illumination in postmenopausal women. BMC Psychiatry. 2004;4:8
  23. Mari JJ, Williams P. A validity study of a psychiatric screening questionnaire (SRQ-20) in primary care in the city of Sao Paulo. Br. J. Psychiatry. 1986;148:23–26
  24. Miller HL, Ekstrom RD, Mason GA, Lydiard RB, Golden RN. Noradrenergic function and clinical outcome in antidepressant pharmacotherapy. Neuropsychopharmacology. 2001;24:617–623
  25. Monteleone P, Forziati D, Orazzo C, Maj M. Preliminary observations on the suppression of nocturnal plasma melatonin levels by short-term administration of diazepam in humans. J. Pineal Res. 1989;6:253–258
  26. Nair NP, Hariharasubramanian N, Pilapil C. Circadian rhythm of plasma melatonin in endogenous depression. Prog. Neurol. Biol. Psychiatry. 1984;8:715–718
  27. Ostrowska Z, Zwirska-Korczala K, Buntner B, Pardela M, Drozdz M. Association of body mass and body fat distribution with serum melatonin levels in obese women either non-operated or after jejunoileostomy. Endocr. Regul. 1996;30:33–40
  28. Paparrigopoulos T. Melatonin response to atenolol administration in depression: indication of beta-adrenoceptor dysfunction in a subtype of depression. Acta Psychiatr. Scand. 2002;106:440–445
  29. Paykel ES. The hamilton scales. In:  Bech P,  Coppen A editor. The Hamilton Scales. New York: Springer; 1999;
  30. Penny R, Stanczyk F, Goebelsmann U. Melatonin: data consistent with a role in controlling ovarian function. J. Endocrinol. Invest. 1987;10:499–505
  31. Rabe-Jablonska J, Szymanska A. Diurnal profile of melatonin secretion in the acute phase of major depression and in remission. Med. Sci. Monit. 2001;7:946–952
  32. Rubin RT, Heist EK, McGeoy SS, Hanada K, Lesser IM. Neuroendocrine aspects of primary endogenous depression. XI. Serum melatonin measures in patients and matched control subjects. Arch. Gen. Psychiatry. 1992;49:558–567
  33. Sekula LK, Lucke JF, Heist EK, Czambel RK, Rubin RT. Neuroendocrine aspects of primary endogenous depression. XV: mathematical modeling of nocturnal melatonin secretion in major depressives and normal controls. Psychiatry Res. 1997;69:143–153
  34. Shafii M, MacMillan DR, Key MP, Derrick AM, Kaufman N, Nahinsky ID. Nocturnal serum melatonin profile in major depression in children and adolescents. Arch. Gen. Psychiatry. 1996;53:1009–1013
  35. Szymanska A, Rabe-Jablonska J, Karasek M. Diurnal profile of melatonin concentrations in patients with major depression: relationship to the clinical manifestation and antidepressant treatment. Neuro. Endocrinol. Lett. 2001;22:192–198
  36. Thompson C, Franey C, Arendt J, Checkley SA. A comparison of melatonin secretion in depressed patients and normal subjects. Br. J. Psychiatry. 1988;152:260–265
  37. Voderholzer U, Laakmann G, Becker U, Haag C, Baghai T, Riemann D, et al. Circadian profiles of melatonin in melancholic depressed patients and healthy subjects in relation to cortisol secretion and sleep. Psychiatry Res. 1997;71:151–161
  38. von Bahr C, Ursing C, Yasui N, Tybring G, Bertilsson L, Rojdmark S. Fluvoxamine but not citalopram increases serum melatonin in healthy subjects—an indication that cytochrome P450 CYP1A2 and CYP2C19 hydroxylate melatonin. Eur. J. Clin. Pharmacol. 2000;56:123–127
  39. Wehr TA, Aeschbach D, Duncan WC. Evidence for a biological dawn and dusk in the human circadian timing system. J. Physiol. 2001;535:937–951
  40. Weissman MM, Wickramaratne P, Adams P, Wolk S, Verdeli H, Olfson M. Brief screening for family psychiatric history: the family history screen. Arch. Gen. Psychiatry. 2000;57:675–682
  41. Wetterberg L, Bergiannaki JD, Paparrigopoulos T, von Knorring L, Eberhard G, Bratlid T, et al. Normative melatonin excretion: a multinational study. Psychoneuroendocrinology. 1999;24:209–226
  42. Wetterberg L, Bratlid T, von Knorring L, Eberhard G, Yuwiler A. A multinational study of the relationships between nighttime urinary melatonin production, age, gender, body size, and latitude. Eur. Arch. Psychiatry Clin. Neurosci. 1999;249:256–262

PII: S0306-4530(06)00049-7

doi: 10.1016/j.psyneuen.2006.02.010

Psychoneuroendocrinology
Volume 31, Issue 6 , Pages 761-768 , July 2006

Article Tools

* Image Usage & Resolution